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HPLC-PDACurrent pre-clinical evidences of Centella focus on its pharmacological effects on normal wound healing
but there are limited studies on the bioactivity of Centella in cellular dysfunction associated with diabetic
wounds. Hence we planned to examine the potential of Centella cordifolia in inhibiting methylglyoxal
(MGO)-induced extracellular matrix (ECM) glycation and promoting the related cellular functions. A
Cell-ECM adhesion assay examined the ECM glycation induced by MGO. Different cell types that con-
tribute to the healing process (fibroblasts, keratinocytes and endothelial cells) were evaluated for their
ability to adhere to the glycated ECM. Methanolic extract of Centella species was prepared and partitioned
to yield different solvent fractions which were further analysed by high performance liquid chromatog-
raphy equipped with photodiode array detector (HPLC-PDA) method. Based on the antioxidant [2,2-
diphenyl-1-picrylhydrazyl (DPPH) assay] screening, anti-glycation activity and total phenolic content
(TPC) of the different Centella species and fractions, the ethyl acetate fraction of C. cordifolia was selected
for further investigating its ability to inhibit MGO-induced ECM glycation and promote cellular distribu-
tion and adhesion. Out of the three Centella species (C. asiatica, C. cordifolia and C. erecta), the methanolic
extract of C. cordifolia showed maximum inhibition of Advanced glycation end products (AGE) fluores-
cence (20.20 ± 4.69 %, 25.00 ± 3.58 % and 16.18 ± 1.40 %, respectively). Its ethyl acetate fraction was
enriched with phenolic compounds (3.91 ± 0.12 mg CAE/lg fraction) and showed strong antioxidant
(59.95 ± 7.18 lM TE/lg fraction) and antiglycation activities. Improvement of cells spreading and adhe-
sion of endothelial cells, fibroblasts and keratinocytes was observed for ethyl acetate treated MGO-
glycated extracellular matrix. Significant reduction in attachment capacity of EA.hy926 cells seeded on
MGO-glycated fibronectin (41.2%) and attachment reduction of NIH3t3 and HaCaT cells seeded on
MGO-glycated collagen (33.7% and 24.1%, respectively) were observed. Our findings demonstrate that
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didate for diabetic wound healing. It could be subjected for further isolation of new phytoconstituents
having potential diabetic wound healing properties.
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The enhanced accumulation of advanced glycation end products
(AGEs) as a result of non-enzymatic glycation of proteins by certain
AGE precursors has been implicated in the pathogenesis of diabetic
complications including impaired wound healing (Peppa et al.,
2009). This complex series of reactions are accelerated when a
reaction occurs between dicarbonyl compounds, such as methyl-
glyoxal (MGO), and amino groups of proteins, lipids and DNA.
Long-lived structural proteins, such as matrix proteins and the
vessel-wall components, have a primary role in maintaining the
normal cellular functions, especially in the healing and regenera-
tive processes. These proteins are a prime target for glycation reac-
tions, which leads to compromised structural and functional
integrity and, as consequence, diminished cellular functions.
Although clinical intervention studies regarding the direct asso-
ciation between extracellular matrix (ECM) proteins glycation and
the progression of chronic wounds are limited, recent evidence has
shown that elevated glycated haemoglobin (HbA1c) and AGEs in
diabetic patients has been associated with diabetic ulcer and
impaired wound healing (Christman et al., 2011; Hu et al., 2012).
Moreover, a large body of experimental reports demonstrated that
the glycation of matrix proteins contributes to impaired cellular
mechanisms and deficient neo-vascularisation in wounds, as
observed in diabetic patients (Niu et al., 2008; Huijberts et al.,
2008; Morita et al., 2005). A wide number of studies have investi-
gated the effects of ECM proteins glycation on cell-ECM interac-
tions and normal cell functions (Chong et al., 2007; Liao et al.,
2009; Loughlin and Artlett, 2009; Murillo et al., 2008). The subse-
quent impairment of cellular functionality, in terms of losing the
ability for the cells to maintain normal adhesion and proliferation
on the ECM, can play a key role in wound chronicity (Liao et al.,
2012). Oxidative stress also plays a pivotal role in the development
of diabetes complications. It was suggested that the induction of
cellular oxidative stress and oxygen free radicals are mediated by
the pro-oxidant property of MGO (Phalitakul et al., 2013; Wu,
2005; Sena et al., 2012), AGEs themselves (Mullarkey et al., 1990)
or as a consequence of the AGEs’ interaction with their receptors
(Lander et al., 1997). Moreover, the oxidation-reduction properties
of MGO-modified proteins leads to catalyzing the formation of free
radicals (Lee et al., 1998). This can explain, in part, the excessive
levels of reactive oxygen species (ROS) in diabetic ulcers that are
associated with defective angiogenesis, excessive inflammation
and impaired cellular functions in response to ischemia (Giacco
and Brownlee, 2010; Schäfer and Werner, 2008; Niu et al., 2012).
Due to the involvement of AGEs and the associated oxidation in
the development of diabetes and several other chronic health con-
ditions, the search for inhibitors of AGEs formation and dicarbonyls
and oxygen-free radical scavengers has become a target of many
biological investigations. An AGE synthetic inhibitor, such as
aminoguanidine, has been unsuccessful in clinical application
due to its side effects such as gastrointestinal disturbances and
abnormalities in liver functions. Some bioactive phytochemicals
possessing redox properties have been shown to inhibit the glyca-
tion process. In particular, flavonoid and phenolic acid compounds
show a highly effective inhibition for the formation of AGEs, with
greater potency than the well-known AGEs inhibitors, including814aminoguanidine (Ashraf et al., 2015; Ghelani et al., 2018a,b). Thus,
using natural products as antiglycative agents is very appealing.
Investigating therapeutic agents that have the potential to scav-
enge the excessive free radicals will facilitate the healing process.
In previous studies, administering vitamin E or N-acetylcysteine
reduced the levels of antioxidant enzymes (catalase, glutathione
peroxidase and lipid peroxides) in diabetic wound animal models,
thus improving the wound healing process (Musalmah et al., 2005;
Dhall et al., 2014). Antioxidant agents such as epigallocatechin gal-
late and a-lipoic acid were shown to accelerate wound healing in
diabetic mice through attenuating AGE-induced receptor for
advanced glycation endproducts (RAGE) protein expression, regu-
lating angiogenesis and decreasing the inflammation (Chen et al.,
2012). Furthermore, inhibiting the reactive oxygen species (ROS)
generation by antioxidant agents restored the MGO-impaired cel-
lular functions that are important for maintaining normal angio-
genesis (Suh et al., 2015; Huang et al., 2013; Alqahtani et al., 2019).
The genus of Centella L. comprises more than 40 species where
they belong to the Apiaceae (Umbelliferae) family (Oskolski and
Wyk, 2010). The majority of these herbaceous perennial species
are endemic to the fynbos region of South Africa, however, several
species are also indigenous to tropical and subtropical regions rep-
resenting warm and moist environments of Asia, Africa, North and
South America. Centella asiatica (L.) Urb., and its very closely
related species, Centella cordifolia (Hook.f.) Nannf, are found to
grow naturally in damp places within tropical and subtropical
regions of Australia. The Australian native species, C. cordifolia, also
named Hydrocotyle cordifolia (Hook.f.), was reported and described
previously in numerous botanical resources (Nannfeldt, 1924;
Harden, 1992; Marchant et al., 1987). Centella erecta (L.f.) Fernald.,
is native to South America and in Eastern and Southern regions of
North America (Rumalla et al., 2010; Barger et al., 2013).
Although current pre-clinical evidences of Centella focus on its
pharmacological effects on normal wound healing, there are lim-
ited studies on the bioactivity of Centella in cellular dysfunction
associated with diabetic wounds. A number of studies have shown
that C. asiatica extract and its triterpene constituents were effective
in enhancing wound healing through promoting tissue regenera-
tion, angiogenesis and inflammation inhibition (Bylka et al.,
2014; Sh Ahmed et al., 2019; Won et al., 2010; Coldren et al.,
2003). However, no study has investigated the effect of C. cordifolia
on carbonyl stress-impaired wound healing. Since C. cordifolia
exerted the strongest antioxidant activities and the highest total
phenolic content with very low variability among the samples
within the species as in our previous work, it was chosen for fur-
ther chemical fractionation and bioactivity investigation
(Alqahtani et al., 2017).
Thus, the aim of this in-vitro study was to investigate the biolog-
ical activities of C. cordifolia using antiglycation-based wound heal-
ing assays. A Cell-ECM adhesion assay (collagen type-I and
fibronectin) was employed which incorporated ECM glycation by
MGO. Different cell types that contribute largely to the healing pro-
cess, fibroblasts, keratinocytes and endothelial cells, were evaluated
for their ability to spread and adhere to glycated ECM. The plant
extract was further fractionated to examine which phytochemical
constituents were responsible for its ability to inhibit MGO-
induced ECM glycation and promote the related cellular functions.
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2.1. Chemicals and cell lines
Rat tail collagen (type I) was purchased from BD Biosciences
(NSW, Australia). Anti-AGEs polyclonal antibody (AB9890) was
purchased from Merck Millipore (VIC, Australia). Other chemicals
and reagents, including bovine serum albumin (BSA), fibronectin
(FN) from bovine plasma, MGO (40% aqueous solution),
aminoguanidine hydrochloride (AG), 6-hydroxy-2,5,7,8-tetrame
thylchroman-2-carboxylic acid (Trolox), 1, 1-diphenyl-2-
picrylhydrazyl (DPPH), Neu’s reagent and trinitrobenzene sulfonic
acid (TNBSA) were purchased from Sigma Aldrich (NSW, Australia).
The human vascular endothelial cell line (EA.hy926) was kindly
provided by Dr Shanhong Ling (Central Clinical School, Monash
University, Australia). The mouse embryonic fibroblasts (NIH3t3)
cell line was kindly provided by Dr Timothy Newsome (School of
Molecular Bioscience, The University of Sydney, Australia). The
human keratinocytes cell line (HaCat) was kindly provided by Dr
Junlae Cho (Faculty of Pharmacy, The University of Sydney,
Australia).
2.2. Cell lines and culture condition
The EA.hy926 endothelial cell line was cultured in Dulbecco
modified eagle medium-F12 (DMEM/Ham’s F12), containing
15 mM hydroxyethyl piperazineethanesulfonic acid (HEPES),
L-glutamine, 100 U/mL of penicillin and streptomycin (Gibco BRL,
Australia) and supplemented with 10% fetal bovine serum
(Bovogen, VIC, Australia), as previously described (Kam et al.,
2014). Both NIH3t3 fibroblasts and HaCat were cultured in DMEM,
containing 4500 mg/L glucose L-glutamine, and 100 U/mL of
penicillin and streptomycin, and supplemented with either 10%
newborn calf serum (Bovogen, VIC, Australia) for NIH3t3 or 10%
fetal bovine serum for HaCat. For all experiments, cells were
seeded at a density of 1  105 cells/mL and allowed to adhere in
T75 flasks. Cells were grown to confluence under 5% carbon dioxide
in a humidified incubator at 37 C prior to the assay.
2.3. Plant samples extraction, fractionation and identification
Plant samples were collected from different locations in New
South Wales, Australia. The collection permit was acquired under
the National Parks and Wildlife Act 1974 from the Office of
Environment and Heritage, New South Wales (NSW), Australia
(License Number: S12282). Authentication was done by the
National Herbarium of NSW, Australia. Voucher specimens
(CA-Li20071014, CC-Li20071014, CE-Li20071014) representing
C. asiatica, C. cordifolia and C. erecta, respectively, were deposited
in the Faculty of Pharmacy, University of Sydney. The extraction
procedure of the Centella plant was outlined in our previous work
(Alqahtani et al., 2017). Briefly, the methanolic extract of plant
(15 g) was suspended in 500 mL of 10% methanol in water and
sequentially fractionated by liquid-liquid partitioning with the sol-
vent of hexane, chloroform, ethyl acetate and n-butanol using a
1000 mL-capacity separation funnel. Each extracted phase, includ-
ing the remaining aqueous phase, was concentrated down with a
vacuum rotary evaporator (LABOROTA 4000, Heidolph Instruments,
Schwabach, Germany) under low pressure and stored at 20 C.
2.4. HPLC-PDA chromatographic condition
High performance liquid chromatography equipped with pho-
todiode array detector (HPLC-PDA) apparatus and chromato-
graphic condition were outlined in our previous work (Alqahtani815et al., 2017). Chromatographic separation was performed in a
reversed-phase C18 Aqua 5m 125 Å (250  4.6 mm) column (Phe-
nomenex, NSW, Australia) coupled with a 1 mm Opti-Guard C18
pre-column (Choice Analytical Pty Ltd., NSW, Australia). The aque-
ous mobile phase (solvent A) was 0.2% phosphoric acid in HPLC-
grade water, while the organic phase (solvent B) was 0.2% phos-
phoric acid in 100% of HPLC grade acetonitrile. The gradient elution
profile, based on the concentration of solvent B, was 0 min, 11%;
18 min, 13%; 33 min, 20%; 43 min, 25%; 50 min, 75%; 52 min,
88%; 64.5 min, 95%; 69 min, 11%; 82 min, 11%. The mobile phase
flowed at a rate of 1 mL/min and the sample injection volume
was 10 mL. The chromatograms were monitored at wavelengths
of 204 nm for the four triterpenes, and 325 and 366 nm for chloro-
genic acid and kaempferol, respectively, via SPD-M30A photodiode
array detector.
2.5. Total phenolic content
Total phenolic content (TPC) was determined as described pre-
viously (Alqahtani et al., 2017). Briefly, 350 mg of different solvent
fractions of C. cordifolia were transferred to a 96-well plate and
mixed with sodium nitrite (NaNO2; 5% w/v) for 5 min, and then
aluminum chloride (AlCl3; 10% w/v) was added. After 6 min, 1 M
sodium hydroxide (NaOH) was added to the mixture and incubated
for 15 min. The absorbance was determined at 515 nm. Catechin
was used as the standard for the calibration curve. Data was pre-
sented as milligram catechin equivalents per either microgram of
the fraction (mg CAE/mg fraction) or gram of dried plant methanolic
extract (mg CAE/g DE of C. cordifolia).
2.6. 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay
The DPPH radical scavenging activity was determined as
described previously (Alqahtani et al., 2017). To evaluate the
antioxidant activity of C. cordifolia fractions, 10 lg of C. cordifolia
fraction were mixed with DPPH radical solution (0.24 mg/mL DPPH
in methanol) and incubated for 30 min. A dose response range (10,
7.5, 5, 3.75, 2.5 and 1.25 microgram/mL) of n-butanol and ethyl
acetate fractions were evaluated. The absorbance was determined
at 515 nm. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid (Trolox) was used for the calibration curve. All values were
expressed as micromolar trolox equivalents per gram of dried
weight (lM TE/g DW).
2.7. In vitro glycation of BSA and matrix proteins
Glycation refers to the non-enzymatic modification of protein
which mainly occurs by a reaction between the primary amino
groups of protein and the reducing sugar. The in vitro glycation
of proteins assay was adapted from previously described methods
with some modification (Liu et al., 2011; Sassi-Gaha et al., 2010).
Bovine serum albumin (BSA; 2 mg/mL) was incubated with
1 mM of MGO in 0.1 M phosphate buffer (pH 7.4) under sterile con-
dition at 37 C at different time points. For the matrix proteins, col-
lagen (30 mg/mL) or fibronectin (13 mg/mL) were incubated with
1 mM of MGO, unless otherwise indicated. Known prototypic AGEs
inhibitors (aminoguanidine and chlorogenic acid) were used as
positive controls as they have been previously shown to inhibit
the glycation process (Kim et al., 2011; Thornalley, 2003;
Gugliucci et al., 2009).
2.8. Detection of AGEs fluorescence and evaluation of anti-glycation
activity using BSA/MGO model
The specific fluorescence intensity of AGEs formed after incuba-
tion of BSA (2 mg/mL) with MGO (1 mM) was measured in several
Fig. 1. Variations in antiglycation activity of the three Centella species. Out of the
three species of Cantella, C. asiatica; CA, C. cordifolia; CC and C. erecta; CE., the
methanolic extract of C. cordifolia showed maximum inhibition of AGE fluorescence.
Values were expressed as % inhibition of AGEs fluorescence per 1 mg/mL of dry
weight (DW) of plant sample. The error bar was calculated from SD, n = 4. Tukey
method, ANOVA *p < 0.05; **p < 0.01; ***p < 0.001.
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fluorescence spectroscope (Shimadzu, Japan). The optimal fluores-
cence intensity for AGEs was detected at 345 and 430 nm of the
respective excitation and emission maxima, respectively. Three
Centella species (C. asiatica, C. cordifolia and C. erecta) were then
evaluated for the inhibition of glycation mediated AGEs fluores-
cence by incubating the methanolic extract with BSA/MGO solu-
tion to the final concentration of 332 mg/mL. C. cordifolia solvents
fractions (83 mg/mL) and their different concentrations of the ethyl
acetate fraction (10.4, 20.8, 41.5, 83 and 166 mg/mL) were evalu-
ated similarly. Vehicle (negative control) or aminoguanidine (pos-
itive control) were used as controls. The fluorescence of MGO and
vehicle (FLblank) was subtracted from the results. The percentage
inhibition was calculated as: % inhibition = [1  (FLsample)/
(FLcontrol)]  100.
IC50 was calculated from percentage inhibition values obtained
at all tested concentrations.
2.9. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) of glycated proteins.
Glycated BSA (0.16 mg) or glycated collagen-type I (3 mg) sam-
ples, as well as untreated control samples, were separated under
reducing condition by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS-PAGE) using Bolt 4–12% Bis-Tris gradient
gels (Life Technology, Australia) at 150 V for 2 h. Proteins were
then visualised after the gels were stained with 0.3% Coomassie
Brilliant Blue R-250 and destained with 0.1% acetic acid.
2.10. Determination of free (non-reacted) amino group by 2,4,6-
trinitrobenzene sulfonic acid (TNBSA) assay
The relative reduction of the free amino groups in the protein as
a result of the modification of amino group residues was deter-
mined by the 2,4,6-trinitrobenzene sulfonic acid (TNBSA) assay
as previously described (Habeeb, 1966; Sattarahmady et al.,
2007; Snyder and Sobocinski, 1975). The reaction mixture of pro-
teins and MGO was diluted with 0.1 M sodium bicarbonate buffer
(pH 8.4) to a concentration of 1 mg/mL for BSA and 0.5 mg/mL for
collagen and fibronectin. Protein samples (140 mL) were mixed
with 70 mL of freshly prepared 0.01% (w/v) TNBSA and incubated
for one hour at 37 C. After the incubation, 70 mL of 10% sodium
dodecyl sulfate (SDS) and 35 mL of 1 N HCL were added to block
the reaction, and the absorbance was measured at 340 nm. Chloro-
genic acid was used as the positive control instead of aminoguani-
dine, since the later has several amino groups which can interfere
with the assay.
2.11. Cell adhesion assay on glycated matrix protein
Cell adhesion was performed using the crystal violet staining
method. Briefly, each well of 48-well plate was coated with either
type I collagen (25 mg/well) or fibronectin (12 mg/well) and incu-
bated at 37 C with 5 or 10 mM MGO for 5 days to induce the gly-
cation. Wells were washed three times with phosphate buffered
saline (PBS) to remove MGO residues and unbound adducts, and
incubated for 1 h with serum-free medium containing 1% BSA
(W/V) to block nonspecific binding sites and then washed twice
with PBS. Cells (250 mL; 1.5  104 cells mL1) were later seeded
on to the coated wells and, after 3 h of incubation, non-attached
cells were removed by washing the wells three times with PBS.
For cell recovery, adherent cells were re-incubated for one hour
and then fixed and stained with crystal violet.
Fibronectin or collagen was incubated with two different
concentrations of MGO; 5 mM or 10 mM prior to cell seeding
for 3 h. Treatment group refers to the co-incubation of816MGO-fibronectin or MGO-collagen with ethyl acetate fraction
(EA) or aminoguanidine (positive control) prior to cell seeding.
The control group refers to the cells plated on native (non-
glycated) fibronectin.
2.12. Statistical analysis
All values are expressed as mean ± standard deviation (SD).
Data were subjected to one-way analysis of variance (ANOVA), fol-
lowed by Newman-Keuls post hoc test or two-way ANOVA fol-
lowed by Bonferroni’s post hoc test where appropriate for
multiple comparisons. A student’s t-test was performed for indi-
vidual comparisons between two groups; statistically significant
differences were accepted at p < 0.05. Statistical analysis was con-
ducted on GraphPad Prism (version 6.05, U.S.A).
3. Results
3.1. Anti-glycation activity of Centella species by AGEs fluorescence
inhibition in BSA/MGO model
The antiglycation activity of the methanolic extract of the three
Centella species was evaluated by detecting their ability to inhibit
the fluorescence of AGEs that is formed during the incubation of
BSA with MGO. All Centella sample extracts, at a final concentration
of 332 mg/mL, reduced AGEs formation as determined by fluores-
cence intensity (Ex/Em = 345/430) (Fig. 1). The results indicated
that antiglycation activity, as calculated from 1 mg/mL of dry plant
material, varied among the samples in the range between 13.16% ±
1.12 to 30.26% ± 1.16, averaging 20.20% ± 4.69, 25.00% ± 3.58 and
16.18% ± 1.40 for C. asiatica, C. cordifolia and C. erecta, respectively.
Significant variability was observed in C. cordifolia when compared
to the other two species, C. erecta and C. asiatica (P < 0.001 and
P < 0.05, respectively), but not between C. asiatica and C. erecta.
This is the first study investigating the antiglycation activity of
the three Centella species.
3.2. Analysis of C. cordifolia methanolic extract and fractions by TLC
and HPLC-PDA
The yield of the crude C. cordifolia methanolic extract was
302 mg extract/g dry plant material which consisted of approxi-
mately 20.8% non-polar (hexane-soluble) components, 22.33%
non-polar (chloroform-soluble) components, 10.1% moderate-
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components and 20.33% highly polar (H2O-soluble) components.
Prior to the activity screening of the fractions, the identification
of major chemical constituents was conducted for each fraction
by thin-layer chromatography (TLC) and HPLC-PDA analysis. Based
on TLC analysis (supplementary, Fig. S1) chlorogenic acid and
kaempferol, together with unknown compounds (most likely other
phenolic acids), were detectable (as highly intense bands) in the
ethyl acetate fraction of C. cordifolia as observed from the TLC plate
sprayed with Neu’s reagent which is specific to react with phenolic
acids and flavonoids. Kaempferol was not detectable in the water
and n-butanol fractions, but present as low intense bands in chlo-
roform and hexane fractions. The result of the HPLC-PDA analysis
of the C. cordifolia fractions (Fig. 2), revealed that the ethyl acetate
fraction contained chlorogenic acid and kaempferol, whereas the
n-butanol fraction contained mainly the principal triterpene glyco-
sides (asiaticoside and madecassoside) together with chlorogenic
acid, thus confirming the TLC findings. Triterpene aglycones
(asiatic acid and madecassic acid) were found in the chloroformFig. 2. HPLC-PDA chromatograms of methanolic extract of different fractions from C. cord
204 nm: madecassoside (1), asiaticoside (2), madecassic acid (3) and asiatic acid (4); at
817fraction together with kaempferol. Several major HPLC peaks were
found in ethyl acetate at a wave length 325 nm (Rt; 19.5 and 29.5),
(Fig. 2A) which are believed to be caffeoylquinic acid derivatives as
reported previously in the Centella plant (Gray et al., 2014). These
compounds have characteristic blue fluorescent bands on the TLC
with Neu’s reagent as shown in Supplementary, Fig. S1.
3.3. Total phenolic content (TPC) of C. cordifolia fractions and their
antioxidant activity
Identifying the total phenolic content and their antioxidant
activity from the-enriched fraction of C. cordifoliawill be promising
for further investigation in carbonyl stress-related cellular dys-
functions. As seen in Fig. 3A, the estimated average of total flavo-
noids in the hexane, chloroform, ethyl acetate, n-butanol and 10%
methanol were 0.92 ± 0.13, 0.86 ± 0.03, 3.91 ± 0.12, 1.22 ± 0.09
and 1.09 ± 0.09 mg CAE/mg fraction, respectively, which is equiva-
lent to 182.46 ± 25.96, 184.19 ± 6.20, 351.58 ± 10.39, 301.94 ± 22.
19 and 209.52 ± 16.77 mg CAE/g dry extract of C. cordifolia, respec-ifolia. A: EtOAc; B: n-BuOH and C: chloroform fraction. Compounds identification; at
325 nm: chlorogenic acid (5) and at 366 nm: kaempferol (6).
Fig. 3. Total phenolic contents (A and B) and antioxidant capacity (C) of different
fractions from C. cordifolia. Total phenolic content of C. cordifolia were presented as
milligram catechin equivalents per microgram of fraction (A) or per gram of dried
plant methanolic extract (B). Antioxidant activity (C) was evaluated by DPPH assay
and expressed as micromolar trolox equivalent (TE) per microgram of C. cordifolia
fraction. The error bar was calculated from SD, (n = 20). Tukey method, ANOVA #
p < 0.0001 compared to other fractions; *p < 0.05 compared to ethyl acetate fraction.
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tion significantly contains much higher flavonoid contents com-
pared to other fractions, followed by n-butanol. The antioxidant
guided fractionation of C. cordifolia was conducted using the DPPH
assay (Fig. 3C). The results indicated that the DPPH radical scav-
enging activity varied among the fractions, with the highest
antioxidant capacity significantly exerted by the ethyl acetate frac-
tion (59.95 ± 7.18 mM TE/mg fraction), followed by n-butanol, 10%
methanol, chloroform and hexane fractions (33.48 ± 4.39, 20.73 ±
2.70, 13.77 ± 4.17 and 6.61 ± 3.73 mM TE/mg fraction, respectively).
Thus, there was a strong association between TPC and the antiox-818idant capacity indicating that phenolic compounds are the main
contributors to this activity.
3.4. Anti-glycation activity of C. cordifolia fractions
With the C. cordifolia fractions showing high antioxidant activity
(Fig. 3C), these fractions were further evaluated for their antiglyca-
tion activity. After 72 h of incubation, the ethyl acetate fraction
(83 mg/mL) exhibited the highest inhibitory activity (31.58% ±
0.77), followed by n-butanol, hexane and chloroform fractions
(28.03% ± 1.03, 17.96% ± 1.34 and 7.74% ± 1.71, respectively) (Fig. 4).
3.5. Dose and time-dependent inhibition of AGE formation by ethyl
acetate fraction
The ethyl acetate fraction of C. cordifolia (83 mg/mL) showed
consistent antiglycation activity during different incubation time-
points. The dose and time-dependent antiglycation activity indi-
cated that the percentage of AGE inhibition increased with the
increasing concentration, as shown in Fig. 5A, and also at different
incubation time-points (72 and 168 h), with IC50 values of 103.4
and 114.4 mg/mL, respectively as shown in Fig. 5B.
3.6. Effect of ethyl acetate fraction on MGO-induced BSA and collagen
migration by SDS-PAGE
The SDS-PAGE electrophoresis of native and glycated forms of
BSA and collagen-type I under reducing condition are presented
in Fig. 6A and Fig. 6B, respectively. The electrophoretic separation
of the BSA shows one band at 64 kDa, while collagen shows five
major bands in the molecular weight range of 97–210 kDa. Accord-
ing to the protein map of MGO-treated BSA, it was found that MGO
(1 mM) had a significant influence on the electrophoretic pattern of
BSA which resulted in lower intensiveness and smearing protein
band compared to untreated protein. The deteriorated effects of
MGO on BSA and collagen-type I was reversed by the treatment
of the ethyl acetate fraction (100 mg/mL).
3.7. Ethyl acetate fraction of C. cordifolia restores the spreading and
attachment of endothelial, fibroblast and keratinocyte cells over the
glycated ECM
Transient interactions between endothelial cells and fibronectin
occur during the neoangiogenesis of wound healing, and several
integrins, including avb3, a3b1 and a5b1 are expressed at this
stage of the process (Clark et al., 1996). Thus, we have investigated
the spreading and adhesion of endothelial, fibroblast and ker-
atinocytes cells to MGO treated ECM-coated wells and their rever-
sal by the ethyl acetate fraction of C. cordifolia.
As shown in Fig. 7, the cell distribution pattern of EA.hy926 was
clearly deteriorated in MGO-glycated fibronectin which had been
incubated with either 5 mM (Fig. 7A) or 10 mM (Fig. 7B) MGO
for 5 days at 37 C. When MGO-fibronectin was incubated with
the ethyl acetate fraction of C. cordifolia (500 mg/mL) or
aminoguanidine (2 mM), cell spreading and distribution were sig-
nificantly improved in comparison to the cells seeded over MGO-
fibronectin without treatment.
As shown in Fig. 8, the cell distribution pattern of NIH3t3
fibroblasts was clearly deteriorated in MGO glycated collagen type
I, which had been incubated with either 5 mM (Fig. 8A) or 10 mM
(Fig. 8B) MGO, for 5 days at 37 C. When MGO-collagen was incu-
bated with the ethyl acetate fraction of C. cordifolia (500 mg/mL) or
aminoguanidine (2 mM), cell spreading, and distribution was sig-
nificantly improved in comparison to the cells seeded over MGO-
collagen without treatment.
Fig. 4. Different fraction of C. cordifolia methanolic extract inhibited BSA-AGEs fluorescence. Inhibition of the glycation-induced AGEs fluorescence by C. cordifolia methanolic
extract (332 mg/mL) and its different fractions (83 mg/mL) during different incubation time-points. Aminoguanidine, AG (500 mM) was used as a positive control. The error bar
was calculated from SD, (n = 20). Tukey method, ANOVA *p < 0.0001 compared to other fractions; # p < 0.05 compared to ethyl acetate fraction.
Fig. 5. Concentration-dependent inhibition of AGEs formation by ethyl acetate
fraction of C. cordifolia: Five days incubation (A) and concentration-dependent
effects with different incubation periods (B) of ethyl acetate fraction of C. cordifolia
methanolic extract. Results are expressed as % inhibition versus the log concentra-
tions. (Means ± SD, n = 8). A logarithmic regression was fitted to the data, with IC50
values calculated from the corresponding regression equation.
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can be affected by ECM glycation by MGO. As shown in Fig. 9A, it
was found that EA.hy926 seeded over MGO-glycated fibronectin,
which had been incubated with either 5 mM or 10 mM of MGO
for 5 days at 37 C, showed a significant reduction (41.2%) in
attachment capacity compared to cells plated on non-glycated819native fibronectin (P < 0.001). When MGO-fibronectin was incu-
bated with the ethyl acetate fraction of C. cordifolia (500 mg/mL)
or aminoguanidine (2 mM), cell adhesion to the fibronectin-
coated wells was significantly improved in comparison to the cells
seeded over MGO-fibronectin without treatment (P < 0.001). As
shown in Fig. 9B, it was found that NIH3t3 fibroblasts seeded onto
MGO-glycated collagen type I, which had been incubated with
5 mM of MGO for 5 days at 37 C, showed a significant reduction
by 33.7% in the attachment capacity compared to cells plated over
non-glycated native collagen (P < 0.001). Next, the adhesion of
keratinocytes on glycated collagen type I was examined. The
human skin keratinocytes (HaCaT) seeded onto MGO-glycated
collagen type I, which had been incubated with 5 mM of MGO
for 5 days at 37 C, showed a significant high reduction in the
attachment capacity by 24.1% comparing to cells plated on non-
glycated native collagen (P < 0.001) (Fig. 9C). When MGO-
collagen was incubated with the ethyl acetate fraction of C. cordi-
folia (500 mg/mL) or aminoguanidine (2 mM), fibroblast Fig. 9B
and keratinocyte Fig. 9C, cells attachment to the collagen-coated
wells was significantly improved in comparison to the cells seeded
onto MGO-collagen without treatment (P < 0.0001).4. Discussion
Impaired wound healing is a complex, patho-physiological pro-
cess and is a major clinical complication in the progression of dia-
betes. Different kinds of cells contribute to the healing process
where maintaining normal cellular response to the injury is crucial
for efficient healing. Improper cellular adaptation to the healing
mechanism can impair the wound healing process as seen in
chronic wounds. Although the fundamental mechanisms of the
impaired healing in diabetic patients remain obscure, diminished
cellular processes in response to the tissue injury have been
observed in diabetes and contribute to the healing deficiency
(Blakytny and Jude, 2006; Brem and Tomic-Canic, 2007). Undoubt-
edly, skin collagen would be a frequent target of the glycation pro-
cess, as it is the most abundant protein in the extracellular matrix
of the skin, and has a slow turnover rate. Therefore, many biologi-
cal investigations for wound healing agents consider AGEs
formation inhibitors and dicarbonyls and oxygen-free radical scav-
engers as promising therapeutic agents.
At an early stage of the Maillard reaction, the carbonyl groups of
MGO react with the free amino groups of the protein, such as
Fig. 6. Ethyl acetate fraction reverse MGO-induced BSA and collagen migratory
defects on SDS-PAGE: SDS-PAGE analysis of control and MGO-treated BSA (A) and
collagen-type I (B). Note BSA protein band aggregate that is detected as a result of
MGO-induced glycation. Co-incubation with aminoguanidine (AG) or ethyl acetate
fraction of C. cordifolia (EA) reverse BSA band integrity and reduce the diffusion. The
migration of cross-linked collagen by MGO was slower than native collagen. Co-
incubation with ethyl acetate reversed the migration behavior of collagen.
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the incubation of proteins with MGO has been shown to irre-
versibly form the AGEs as a result of protein glycation that is asso-
ciated with the generation of protein-bound free radicals
(Thornalley, 1996). The majority of the generated AGEs have fluo-
rescent characteristics that can be detected at 345/430 nm, and
their intensity can indicate the degree of protein glycation
(Schmitt et al., 2005).
As shown in Supplementary, Fig. 2, it was found that the incu-
bation of 2 mg/mL of BSA with 1 mM of MGO was accompanied by
a time-dependent elevation of AGEs fluorescence at 345/430 nm
(Supplementary, Fig. 2A). After incubating for 96 h, the fluores-
cence intensity was increased by 37.7% from the reading that
was obtained on the first three days of incubation. This indicates
that the fast glycation reaction was induced by MGO. The formed
AGEs fluorescence was reversed by co-incubation with
aminoguanidine (200 mM), a known antiglycation agent that has
been used extensively as a control in the literature. The results820obtained from the TNBSA assay showed a significant reduction in
the availability of the free amino groups indicating that both BSA
and collagen were undergoing glycation by MGO. The availability
of free amino groups of BSA was reduced by 21.06% and 27.17%
after the incubation periods of 72 and 120 h, respectively (Supple-
mentary, Fig. 2B). The availability of the free amino groups of col-
lagen was reduced by 22.48% after the incubation period of 120 h
(Supplementary, Fig. 2C). This indicates the chemical modification
of the arginine and lysine residues of the proteins as reported pre-
viously (Degenhardt et al., 1998). The glycation reaction was signif-
icantly reversed by aminoguanidine (200 mM) in AGEs fluorescence
inhibition assay (p < 0.0001) and by chlorogenic acid (100 mM) in
the detection of albumin’s (p < 0.0001) and collagen’s (p < 0.05) free
amino groups. Those compounds have been shown previously to
inhibit protein glycation ((Kim et al., 2011; Thornalley, 2003).
Several studies have shown that C. asiatica extract and its triter-
pene constituents were effective in enhancing wound healing
through promoting tissue regeneration, angiogenesis and inflam-
mation inhibition. However, no study has investigated the effect
of C. cordifolia on diabetic wounds, especially on carbonyl stress-
impaired wound healing. Due to the major involvement of free rad-
icals in the formation of AGEs and the consecutive generation of
cellular oxidative stress by AGEs adducts, the evaluation of the
antioxidative properties of the three Centella species (C. asiatica,
C. cordifolia and C. erecta) were previously studied by our group
(Alqahtani et al., 2017). Our previous study revealed that the total
antioxidant capacities of the methanolic extracts of C. cordifolia is
significantly higher than C. asiatica and C. erecta (Alqahtani et al.,
2017). Similarly, in this study, the antiglycation activity of C. cordi-
folia was the highest among the species whereby its ethyl acetate
fraction exerted the most potent antioxidant and antiglycation
activities among other fractions.
On the basis of identifying the phenolic-enriched fraction with
the most potent antioxidant activity of C. cordifolia, further investi-
gation in the carbonyl stress-related cellular dysfunctions is war-
ranted. The result of HPLC analysis showed that the ethyl acetate
fraction mainly contained chlorogenic acid and kaempferol com-
pound, and there were several peaks in this fraction which are
believed to be caffeoylquinic acid derivatives as reported previ-
ously in the Centella plant (Gray et al., 2014). Moreover, the TPC
assay indicated that the ethyl acetate fraction significantly con-
tained much higher phenolic contents compared to other fractions
followed by n-butanol. In this regard, there is a strong correlation
between TPC and the antioxidant capacity, suggesting that pheno-
lic compounds are the main contributors to this activity.
With C. cordifolia fractions contributing to the higher antioxi-
dant activity, these fractions were evaluated for antiglycation
activity. The pattern of inhibiting the glycation-induced AGEs fluo-
rescence was consistent with the increase in incubation time from
120 h to 168 h. The current study shows a considerable association
between TPC, antioxidant and antiglycation activity which sug-
gests that the inhibition of AGEs formation may be through the
antioxidative potency of the phenolic compounds (Wu and Yen,
2005). Since kaempferol and chlorogenic acid were identified in
the ethyl acetate fraction, their contribution to the inhibition of
AGEs formation by MGO is further supported as described previ-
ously (Wu and Yen, 2005). Previous studies have shown that the
IC50 of the antiglycation activity of kaempferol and chlorogenic
acid in the MGO-BSA reaction was found to be 136.5 and
282.2 mM, respectively (Mesías et al., 2014). This is better than
aminoguanidine activity (standard antiglycative agent), with an
IC50 of 5 mM (Wu and Yen, 2005). While the chloroform fraction
was shown to contain a reasonable content of kaempferol, it was
the least to exert antiglycation activity. This may suggest that
chlorogenic acid preferentially contributes to the activity as it
was present in the most active fractions (ethyl acetate and n-
Fig. 7. Effects of ethyl acetate fraction of C. cordifolia on EA.hy926 endothelial cells population and distribution in glycated fibronectin matrices: Fibronectin was incubated
with two different concentrations of MGO; 5 mM (A) or 10 mM (B) prior to cell seeding for 3 h. Treatment group refer to co-incubation of MGO-fibronectin with ethyl acetate
fraction (EA) or aminoguanidine (+ve control) prior to cell seeding. Control group refers to the cells plated on native (non-glycated) fibronectin.
Fig. 8. Effects of ethyl acetate fraction of C. cordifolia on NIH3t3 fibroblasts population and distribution in glycated collagen type I matrices: Collagen was incubated with two
different concentrations of MGO; 5 mM (A) or 10 mM (B) prior to cell seeding for 3 h. The treatment group refers to the co-incubation of MGO-collagen with ethyl acetate
fraction (EA) or aminoguanidine (+ve control) prior to cell seeding. The control group refers to the cells plated on native (non-glycated) fibronectin.
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Fig. 9. Effects of ethyl acetate fraction of C. cordifolia on cell adhesion in glycated
ECM: Endothelial cells adhesion is significantly altered on MGO-fibronectin (A).
Fibroblast (B) and keratinocytes (C) adhesion to MGO-collagen is significantly
reduced. Ethyl acetate fraction (EA) and aminoguanidine (AG) co-incubation with
MGO-fibronectin or MGO-collagen improved cell adhesion significantly. Cell
adhesion was expressed as % of control. The error bar was calculated from SD,
(n = 5). Tukey method, ANOVA, ***p < 0.0001 compared to non-treatment group.
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activity and increased the glycation process. This is probably due
to the presence of very polar polysaccharides constituents that
can induce protein glycation. As the n-butanol fraction also con-
tained the principal triterpenes of Centella (asiaticoside and made-
cassoside), these compounds were further tested for their activity.
The results showed that these compounds were not active in the
antiglycation assay (data not shown).
On the basis of SDS-PAGE electrophoretic pattern of native and
glycated forms of BSA and collagen-type I under reducing condi-
tion, the observed electrophoretic changes of the glycated822collagen-type I characterised by slower migratory property com-
paring to the native one, indicating the ability of MGO to promote
cross-linking of collagen monomers into larger aggregates. This is
comparable with a previous study, however, collagen migration
inhibition was clearly shown only when the MGO concentration
was increased to 10-fold (Chong et al., 2007). The presence of the
ethyl acetate fraction of C. cordifolia (100 mg/mL) in the incubation
mixture leads to the inhibition of the deteriorated effects of MGO
on BSA and collagen-type I. The inhibition of BSA glycation by ethyl
acetate was comparable to the aminoguanidine (positive control).
Previous findings demonstrated that kaempferol, chlorogenic acid
(identified in the ethyl acetate fraction of C. cordifolia), as well as
phenolic acid and hydroxysafflor yellow A, exerted similar effects
in SDS-PAGE observation and protected BSA integrity from MGO-
induced glycation (Wu and Yen, 2005; Ni et al., 2012).
Chlorogenic acid has been shown to inhibit AGEs formation and
AGEs cross-linking of collagen (IC50 = 148.32 mM) [45]. Thus, on the
basis of earlier reports which demonstrated that kaempferol was
shown to be the least effective in inhibiting the formation of the
cross-linking AGE (pentosidine) in collagen compared to other fla-
vonoids, our results suggest that the antiglycation effect of ethyl
acetate fraction of C. cordifolia preferentially attributed to chloro-
genic acid rather than kaempferol (Urios et al., 2007).
The complexity of the cell functionality cascade during wound
healing requires different cell types to perform a number of dis-
tinct micro-environmental interactions with their surrounding
extracellular matrix. It was investigated whether cell adhesion to
ECM-coated wells can be affected by ECM glycation by MGO. The
cell distribution pattern was clearly deteriorated in MGO glycated
fibronectin. This is in agreement with a previous study that
showed MGO-modified fibronectin reduced the adhesion and
spreading capacity of retinal microvascular endothelial cells which
is suggested to be through specific arginine modification in RGD
(Arg-Gly-Asp) and GFOGER (Gly-Phe-Hyp-Gly-Glu-Arg) integrin
binding sites (McDonald et al., 2009; Dobler et al., 2006). Therefore,
it is likely that MGO modification of fibronectin, mainly the RGD
sites, will impair angiogenesis in diabetes (Lund et al., 2011). More-
over, the cell distribution pattern was clearly compromised in
MGO-glycated collagen especially with high concentrations of
MGO. This is in agreement with previous studies that showed gly-
cated type I collagen reduced the attachment capacity of skin
fibroblasts (Liao et al., 2009; Loughlin and Artlett, 2009).
The reduction in the adhesion of keratinocytes (HaCaT) on gly-
cated collagen type I, as examined in our study, is in agreement
with a previous study that showed that keratinocytes adhesion
to glycated type I collagen was highly reduced in comparison to
native non-glycated collagen, where a2b1 integrin was responsible
(Morita et al., 2005). Overall, the C. cardifolia ethyl acetate fraction
was able to reverse the capability of the cells to spread and adhere
to ECM that were exposed to MGO.5. Conclusion
Advanced glycation end products are implicated in the impaired
wound healing process in diabetes. Disrupted cellular functions
due to highly reactive carbonyls and ECM cross-linking can affect
the cellular response to tissue injury and hence, normal wound
healing. Centella cordifolia (Hook.f.) Nannf, is native to Australia
and traditionally used for wounds healing, however, no study has
investigated the effect of C. cordifolia on carbonyl stress-cellular
model. In summary, this study demonstrates that the ethyl acetate
fraction of C. cordifolia was effective in attenuating MGO-induced
glycation and cellular dysfunction in the in-vitro wound healing
models, and that the ethyl acetate fraction may be a potential can-
didate for further development as a medicinal product for wound
A.S. Alqahtani, K.M. Li, V. Razmovski-Naumovski et al. Saudi Journal of Biological Sciences 28 (2021) 813–824healing. The isolation and identification of active compounds from
ethyl acetate fraction of C. cordifolia is required and in vivo wound
healing activities in diabetic models are warranted.
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